STOMP: Small cell lung cancer trial of olaparib (AZD2281) as maintenance programme - a randomised, double blind, multicentre NCRN phase II trial

被引：0
|
作者：
Woll, P. J. [1 ]
Jarrett, H. [2 ]
Billingham, L. [2 ]
机构：
[1] Univ Sheffield, Weston Pk Hosp, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Birmingham, CRUK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
来源：
LUNG CANCER | 2011年 / 71卷
关键词：
D O I：
10.1016/S0169-5002(11)70121-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [31] Single agent gemcitabine in pretreated patients with non small cell lung cancer: results of an Argentinean multicentre phase II trial
    Van Kooten, M
    Traine, G
    Cinat, G
    Cazap, E
    Comba, AZ
    Vicente, H
    Sena, S
    Nievas, OR
    Orlando, M
    BRITISH JOURNAL OF CANCER, 1999, 81 (05) : 846 - 849
  • [32] Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
    Tell, Roger
    Sederholm, Christer
    Klintenberg, Claes
    Franksson, Lars
    Branden, Eva
    Hillerdal, Gunnar
    Lonn, Ulf
    Linden, Carl-Johan
    Ewers, Sven-Borje
    Lamberg, Kristina
    Mrazek, Eva
    Loden, Britta
    Sjogren, Anders
    Linne, Thomas
    Friesland, Signe
    Sirzen, Florin
    ANTICANCER RESEARCH, 2008, 28 (5B) : 2851 - 2857
  • [33] Biomarker driven phase II umbrella trial study of AZD1775,AZD2014,AZD2811 monotherapy in relapsed small cell lung cancer.
    Park, Sehhoon
    Shim, Joonho
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Park, Woong-Yang
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] REACT study: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients
    von Minckwitz, G.
    Conrad, B.
    Denkert, C.
    Eidtmann, H.
    Eiermann, W.
    Harbeck, W.
    Huober, J.
    Jackisch, C.
    Lueck, H.
    Moebus, V.
    Reimer, T.
    Rody, A.
    Stickeler, E.
    BREAST, 2009, 18 : S56 - S56
  • [35] RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.
    Raja, F. A.
    Perren, T. J.
    Embleton, A.
    Rustin, G. J. S.
    Jayson, G.
    Swart, A. M.
    Vaughan, M.
    Hirte, H.
    Stark, D. P.
    Ledermann, J. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [36] Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer
    Fennell, Dean A.
    Steele, Jeremy P. C.
    Shamash, Jonathan
    Slater, Sarah E.
    Sheaff, Michael T.
    Wells, Paula
    Rudd, Robin M.
    Stebbing, Justin
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (11) : 2575 - 2577
  • [37] Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer
    Woll, PJ
    Basser, R
    LeChevalier, T
    Drings, P
    Manga, GP
    Adenis, A
    Seymour, L
    Smith, F
    Thatcher, N
    BRITISH JOURNAL OF CANCER, 1997, 76 (02) : 264 - 265
  • [38] Phase II trial of gemcitabine in advanced non-small-cell lung cancer
    Malayeri, R
    Ulsperger, E
    Baumgartner, G
    Forstner, B
    Aigner, K
    Hubner, M
    Kummer, F
    Krajnik, G
    Zochbauer, S
    Krejcy, K
    Huber, H
    Pirker, R
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (17) : 688 - 691
  • [39] Phase II trial of docetaxel and topotecan in recurrent and extensive small cell lung cancer
    Gormley, N
    Edelman, MJ
    Smith, R
    Hausner, PF
    Bedor, M
    Bisaccia, S
    LUNG CANCER, 2004, 46 : S42 - S43
  • [40] A phase II trial of pazopanib in relapsed/refractory small cell lung cancer (SCLC).
    Gandhi, Leena
    Heist, Rebecca Suk
    Lucca, Joan Vern
    Temel, Jennifer S.
    Fidias, Panos
    Morse, Linda K.
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345